[144] Brinker International, Inc. SEC Filing
Rhea-AI Filing Summary
Brinker International, Inc. (EAT) Form 144 — An insider plans to sell 44,000 shares of common stock through Fidelity Brokerage Services on the NYSE, with an approximate sale date of 08/27/2025. The filing reports an aggregate market value of $6,944,218.58 and total shares outstanding of 44,498,111. The shares were acquired by restricted stock vesting from the issuer on 08/19/2025 and were received as compensation with payment dated 08/19/2025. The filer indicates no sales in the prior three months and includes the standard signature representation about absence of undisclosed material information.
Positive
- Full disclosure of material Rule 144 fields: class, quantity (44,000), acquisition date (08/19/2025), and intended sale date (08/27/2025)
- Transaction source is clear: shares acquired via restricted stock vesting and received as compensation
Negative
- No indication of a 10b5-1 plan or plan adoption date is provided in the filing
- Filing lacks identifying filer details such as the filer CIK or name in the visible content
Insights
TL;DR: A recent restricted-stock vesting will be sold: 44,000 shares valued at roughly $6.94M on 08/27/2025 via Fidelity on NYSE.
The filing documents a routine Rule 144 notice for shares received as compensation. The position size (44,000 shares) and stated aggregate value are disclosed, along with the timing of acquisition and intended sale. There is no disclosure of prior sales in the last three months. This is a compliance filing indicating an insider intends to sell shares that became eligible after vesting; the document does not provide any forward-looking commentary or context beyond the mechanics of the proposed sale.
TL;DR: Filing is a procedural disclosure of an insider sale after restricted stock vesting, with standard representations included.
The notice meets Rule 144 reporting requirements by specifying class, quantity, acquisition type, acquisition date, and broker. It confirms the shares resulted from issuer-granted restricted stock vesting and were paid as compensation. The filing contains the statutory attestation that no undisclosed material adverse information is known, and no 10b5-1 plan date is stated. There is no additional governance or material event disclosed here.